FI58435C - Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning - Google Patents

Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning Download PDF

Info

Publication number
FI58435C
FI58435C FI781858A FI781858A FI58435C FI 58435 C FI58435 C FI 58435C FI 781858 A FI781858 A FI 781858A FI 781858 A FI781858 A FI 781858A FI 58435 C FI58435 C FI 58435C
Authority
FI
Finland
Prior art keywords
solution
och
vattenhaltig
sulphonamidaktivator
intravenoesduglig
Prior art date
Application number
FI781858A
Other languages
English (en)
Finnish (fi)
Other versions
FI58435B (fi
FI781858A (fi
Inventor
Karl Dr Groke
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of FI781858A publication Critical patent/FI781858A/fi
Publication of FI58435B publication Critical patent/FI58435B/fi
Application granted granted Critical
Publication of FI58435C publication Critical patent/FI58435C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI781858A 1977-07-08 1978-06-09 Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning FI58435C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2731013A DE2731013C2 (de) 1977-07-08 1977-07-08 Verfahren zur Herstellung einer wäßrigen Infusionslösung
DE2731013 1977-07-08
AT498477 1977-07-12
AT498477A AT351166B (de) 1977-07-08 1977-07-12 Verfahren zur herstellung einer gut ver- traeglichen, intravenoes zu verabreichenden, waessrigen loesung

Publications (3)

Publication Number Publication Date
FI781858A FI781858A (fi) 1979-01-09
FI58435B FI58435B (fi) 1980-10-31
FI58435C true FI58435C (fi) 1981-02-10

Family

ID=25601735

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781858A FI58435C (fi) 1977-07-08 1978-06-09 Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning

Country Status (16)

Country Link
US (1) US4327084A (nl)
JP (1) JPS5417109A (nl)
AT (1) AT351166B (nl)
BE (1) BE862348A (nl)
CH (1) CH637826A5 (nl)
CS (1) CS208479B2 (nl)
DD (1) DD138506A1 (nl)
DE (1) DE2731013C2 (nl)
DK (1) DK159957C (nl)
FI (1) FI58435C (nl)
FR (1) FR2396550A1 (nl)
GB (1) GB1561562A (nl)
IE (1) IE47876B1 (nl)
LU (1) LU79930A1 (nl)
NL (1) NL179704C (nl)
ZA (1) ZA783677B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
FI871447A (fi) * 1986-04-07 1987-10-08 Bristol Myers Co Stabila injicerbara antivomitiva kompositioner.
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
DE4331147A1 (de) * 1993-09-14 1995-03-16 Nycomed Arzneimittel Gmbh Intravenös verabreichbare, wäßrige Lösung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
SE322866B (nl) * 1966-12-15 1970-04-20 Astra Ab
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
JPS4911403B1 (nl) * 1970-12-29 1974-03-16
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations

Also Published As

Publication number Publication date
DD138506A1 (de) 1979-11-07
DE2731013C2 (de) 1982-07-15
FI58435B (fi) 1980-10-31
FI781858A (fi) 1979-01-09
NL179704B (nl) 1986-06-02
NL179704C (nl) 1986-11-03
JPS5417109A (en) 1979-02-08
FR2396550B1 (nl) 1980-06-13
DK159957C (da) 1991-05-27
DK243378A (da) 1979-01-09
JPS5639285B2 (nl) 1981-09-11
BE862348A (fr) 1978-06-27
AT351166B (de) 1979-07-10
FR2396550A1 (fr) 1979-02-02
US4327084A (en) 1982-04-27
IE47876B1 (en) 1984-07-11
LU79930A1 (nl) 1978-12-07
CH637826A5 (de) 1983-08-31
GB1561562A (en) 1980-02-27
ATA498477A (de) 1978-12-15
DE2731013A1 (de) 1979-01-11
NL7806664A (nl) 1979-01-10
IE781283L (en) 1979-01-08
DK159957B (da) 1991-01-07
ZA783677B (en) 1979-07-25
CS208479B2 (en) 1981-09-15

Similar Documents

Publication Publication Date Title
Churchill et al. Nephrotoxicity associated with combined gentamicin–amphotericin B therapy
FI58435C (fi) Foerfarande foer framstaellning av en intravenoesduglig sulfonamid och sulfonamidaktivator innehaollande vattenhaltig infusionloesning
KR20060096411A (ko) 테트로도톡신의 안정한 동결건조 제약 제제
US9427398B2 (en) Parenteral solutions containing metolazone
JPH0430924B2 (nl)
US4181731A (en) Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
US4663348A (en) Furosemide salts and pharmaceutical preparations thereof
US5281588A (en) Organometallic compounds, methods for their preparation and pharmaceutical compositions containing them
US4002741A (en) Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US4698361A (en) Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same
US4968673A (en) Use of a thromboxane receptor antagonist in renal diseases and dysfunction
GB2030863A (en) Antibacterial compositions
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
US4719213A (en) Anti-cancer composition for delivering 5-fluorouracil
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
IL80787A (en) Pharmaceutical compositions containing derivatives of acetic acid anhydride and a process for preparing such compositions
US3299124A (en) Tetracycline cyclohexyl sulphamate and process for preparation
US4981852A (en) Chemical compounds triamterene and hydrochlorothiazide
US3519712A (en) Therapeutic compositions comprising n-methylglucamine and coumermycin or salts thereof
US6060498A (en) Composition containing antitumor agent
DE3843059A1 (de) Waessrige formulierungen, die ein piperidinylcyclopentylheptensaeure-derivat enthalten
EP0312132B1 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
Kneer Pharmacokinetic properties of new oral cephalosporins
KR20050022250A (ko) 녹차카테킨을 유효성분으로 포함하는 간 기능 개선제
EP4385505A1 (en) Anti-hypoxic/anoxic injury use of magnolol and/or honokiol aromatic ring amino-substituted derivative, and pharmaceutical composition

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: HAFSLUND NYCOMED PHARMA